Side effects and photosensitization of human tissues after aminolevulinic acid.
暂无分享,去创建一个
[1] D. Kessel,et al. Feasibility of photodynamic therapy using endogenous photosensitization for colon cancer. , 1996, Archives of surgery.
[2] J Moan,et al. DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA , 1995, Photochemistry and photobiology.
[3] B. Henderson,et al. PHOTOSENSITIZATION OF MURINE TUMOR, VASCULATURE and SKIN BY 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRIN , 1995, Photochemistry and photobiology.
[4] T. Hasan,et al. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. , 1995, The Journal of urology.
[5] R. Lambert,et al. Long-term survival after photodynamic therapy for esophageal cancer. , 1995, Gastroenterology.
[6] A Gorchein,et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study. , 1995, Gut.
[7] J. Kennedy,et al. Using δ-Aminolevulinic Acid in Cancer Therapy , 1994 .
[8] H. Kerl,et al. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. , 1994, Journal of the American Academy of Dermatology.
[9] I. Driver,et al. Tumor vascular shutdown following photodynamic therapy based on polyhematoporphyrin or 5-aminolevulinic Acid. , 1994, International journal of oncology.
[10] J. Reguła,et al. Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival. , 1994, British Journal of Cancer.
[11] P. Speight,et al. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid , 1993, The Lancet.
[12] A. J. MacRobert,et al. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. , 1993, British Journal of Cancer.
[13] S. Steinberg,et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. , 1993, International journal of radiation oncology, biology, physics.
[14] J Moan,et al. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5‐aminolevulinic acid in mice bearing mammary carcinoma , 1992, International journal of cancer.
[15] S. G. Bown,et al. Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. , 1992, British Journal of Cancer.
[16] R. van Hillegersberg,et al. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. , 1992, Gastroenterology.
[17] J C Kennedy,et al. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.
[18] D. Phillips,et al. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. , 1992, British Journal of Cancer.
[19] M. M. el-Sharabasy,et al. Porphyrin metabolism in some malignant diseases. , 1992, British Journal of Cancer.
[20] N. Schoenfeld,et al. The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders. , 1988, Cancer letters.
[21] L. Leibovici,et al. Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer , 1988, Cancer.
[22] E Glatstein,et al. PROTECTION AGAINST DIHEMATOPORPHYRIN ETHER PHOTOSENSITIVITY , 1988, Photochemistry and photobiology.
[23] H. Barr,et al. Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation. , 1987, British Journal of Cancer.
[24] Thomas S. Mang,et al. THE THEORY OF PHOTODYNAMIC THERAPY DOSIMETRY: CONSEQUENCES OF PHOTO‐DESTRUCTION OF SENSITIZER , 1987 .
[25] William R. Potter,et al. The Theory Of Photodynamic Therapy Dosimetry: Consequences Of Photodestruction Of Sensitizer , 1987, Other Conferences.
[26] N. Schoenfeld,et al. Increased porphobilinogen deaminase activity in patients with malignant lymphoproliferative diseases. A helpful diagnostic test. , 1987, JAMA.
[27] W. Star,et al. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. , 1986, Cancer research.
[28] H. Dailey,et al. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. , 1984, The Biochemical journal.
[29] M. Valsamis,et al. Abnormal iron and water metabolism in acute intermittent porphyria with new morphologic findings. , 1972, The American journal of medicine.
[30] A. Neuberger,et al. The metabolism of δ-aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N , 1956 .
[31] D. Kessel,et al. Photodynamic Therapy Using Endogenous Photosensitization for Gastrointestinal Tumors , 1997, The Yale Journal of Biology and Medicine.
[32] E G Hahn,et al. Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid. , 1995, Gastrointestinal Endoscopy.
[33] H Kerl,et al. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? , 1993, Journal of the American Academy of Dermatology.
[34] R. van Hillegersberg,et al. Photodynamic therapy for gastrointestinal tumors. , 1991, Scandinavian journal of gastroenterology. Supplement.
[35] N. Navone,et al. Heme biosynthesis in human breast cancer--mimetic "in vitro" studies and some heme enzymic activity levels. , 1990, The International journal of biochemistry.